Turn on and tune in to evidence-based psychedelic research

Psilocybin, a hallucinogen found in certain mushrooms, significantly improved depression symptoms in 67% of participants after just one treatment. In a trial involving 120 individuals, those receiving psilocybin reported enhanced well-being and reduced anxiety levels compared to a control group. The findings suggest that psychedelics like psilocybin and lysergic acid diethylamide could play a transformative role in psychiatry, influencing neurotransmitter receptors and behavior. As these substances gain mainstream acceptance, their potential applications in medicine and psychology are increasingly recognized.

Study at a glance

Abstract

No abstract available from the source.